Key Metrics of PetMed Express
Revenue$274M▲ 10.7% YoYFY 2023
Operating income−$8.2M▼ 234.9% YoY
Net profit−$7.5M▼ 245.1% YoY
Shareholders' equity$100M
Market cap$26.4MPETS · $1.22
Competitors10identified
About PetMed Express
Sectors
Company details
- Website
- 1800petmeds.com
- Listed
- Nasdaq: PETS
Operational Areas of PetMed Express
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal namePetMed Express Inc.
TickerPETS
ExchangeNasdaq
CountryUnited States
SEC CIK0001040130
Listed since—
IndustryRetail-Drug Stores and Proprietary Stores
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttp://www.1800petmeds.com
US market & SEC filings
PETS · Nasdaq · SEC CIK 0001040130
Last price · 26 Oct 2026
$1.22
+3.39%
Market cap$26.4M
P/E—On FY 2023 diluted EPS
Volume272,247
SectorConsumer StaplesRetail-Drug Stores and Proprietary Stores
Country · IPOUnited States
PETS share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officePompano Beach
GSTIN—
Email—
Websitehttp://www.1800petmeds.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of PetMed Express
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
veterinary medicine
Filings
No filings on record yet.